Phenotypic heterogeneity and disease course in three murine strains with mutations in genes encoding for α1 and β glycine receptor subunits

Movement Disorders

Volumn 12, Issue 2, 1997, Pages 221-228

  Simon, Ely S ^a,b  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^b TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

Author keywords

Chloride channel; Glycine; Hyperekplexia; Myoclonus; Spasticity; Spinal cord

Indexed keywords

GLYCINE RECEPTOR; RECEPTOR SUBUNIT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOSOMAL RECESSIVE INHERITANCE; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; EXPLORATORY BEHAVIOR; GAIT DISORDER; GENE MUTATION; HOMOZYGOTE; HYPERKINESIA; MOTOR DYSFUNCTION; MOUSE; MUSCLE RIGIDITY; MYOCLONUS; NONHUMAN; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; SPASTICITY; SYMPTOM; TREMOR; VIDEOTAPE;

ANIMALS; CHROMOSOME ABERRATIONS; CHROMOSOME DISORDERS; DNA MUTATIONAL ANALYSIS; FEMALE; GENES, RECESSIVE; HETEROZYGOTE DETECTION; HUMANS; MALE; MICE; MICE, NEUROLOGIC MUTANTS; MOTOR ACTIVITY; PHENOTYPE; RECEPTORS, GLYCINE; SPECIES SPECIFICITY; SPINAL CORD;

EID: 0030970098     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/mds.870120213     Document Type: Article

References (25)

1. Shiang R, Ryan S, Zhu Y, Hahn A, O'Connell P, Wasmuth J. Mutations in the alphal subunit of the inhibitory glycine receptor cause the dominant neurologic disorder, hyperekplexia. Nature Genet 1993;5:351-358.
2. Chung E, Yocca F, Van Woert M. Urea-induced myoclonus: medullary glycine antagonism as mechanism of action. Life Sci 1985;36:1051-1058.
3. Chung E, Van Woert M. Urea myoclonus: possible involvement of glycine. Adv Neurol 1986;43:565-568.
4. Pranzatelli M, Tkach K. Regional glycine receptor binding in the p,p′-DDT myoclonic rat model. Arch Toxicol 1992;66:73-76.
5. Truong D, De Yebenes J, Pezzoli G, Jackson-Lewis V, Fahn S. Glycine involvement in DDT-induced myoclonus. Mov Disord 1988;3:77-87.
6. Hall P, Smith J, Lane J, Mote T, Campbell R. Glycine and experimental spinal spasticity. Neurology 1979;29:262-267.
7. Simpson R, Robertson C, Goodman J. Glycine: an important potential component of spinal shock. Neurochem Res 1993;18:887-892.
8. Snodgrass S. Myoclonus: Analysis of monoamine, GABA, and other systems. FASEB J 1990;4:2775-2788.
9. Chai C. Hereditary spasticity in mice. J Hered 1961;52:241-243.
10. Chai C, Roberts E, Sidman R. Influence of aminooxyacetic acid, a gamma-aminobutyrate transaminase inhibitor, on hereditary spastic defect in the mouse. Proc Soc Exp Biol Med 1961;109:491-495.
11. Lane P, Ganser A, Kerner A-L, White W. Spasmodic, a mutation on chromosome 11 in the mouse. J Hered 1987;78:353-356.
12. Kingsmore S, Giros B, Suh D, Bieniarz M, Caron M, Seldin M. Glycine receptor beta subunit gene mutation in spastic mouse associated with LINE-1 element mutation. Nature Genet 1994;7:136-142.
13. Becker C-M, Hermans-Borgmeyer I, Schmitt B, Betz H. The glycine receptor deficiency of the mutant mouse spastic: evidence for normal glycine receptor structure and localization. J Neurosci 1986;6:1358-1364.
14. Becker C-M, Schmieden V, Tarroni P, Strasser U, Betz H. Isoform-selective deficit of glycine receptors in the mutant mouse spastic. Neuron 1992;8:283-289.
15. Heller A, Hallett M. Electrophysiological studies with the spastic mutant mouse. Brain Res 1982;234:299-308.
16. Ryan S, Buckwalter M, Lynch J, et al. A missense mutation in the gene encoding the alphal subunit of the inhibitory glycine receptor in the spasmodic mouse. Nature Genet 1994;7:131-135.
17. Becker C-M, Mulhardt C, Saul B, et al. Mutations of glycine receptor genes in mouse mutants spastic and spasmodic. Soc Neurosci Abst 1994;20:1125.
18. Buckwalter M, Cook S, Davisson M, White W, Camper S. A frameshift mutation in the mouse alpha1 glycine receptor gene (Glra1) results in progressive neurological symptoms and juvenile death. Hum Mol Genet 1994;3:2025-2030.
19. Chai C. Hereditary spasticity in mice. J Hered 1961;52:241-243.
20. Buckwalter M, Testa C, Noebels J, Camper S. Genetic mapping and evaluation of candidate genes for spasmodic, a neurological mouse mutation with abnormal startle response. Genomics 1993;17:279-286.
21. A in the pathogenesis of spinal myoclonus: in vitro studies in the isolated neonatal rodent spinal cord. Neurology 1994;45:1883-1892.
22. Matsumoto J, Fuhr P, Nigro M, Hallett M. Physiological Abnormalities in hereditary hyperekplexia. Ann Neurol 1992;32:41-50.
23. Floeter M, Andermann F, Andermann E, Nigro M, Hallett M. Physiological studies of spinal inhibitory pathways in patients with hereditary hyperekplexia. Neurology 1996;46:766-772.
24. Russell E. Hereditary anemias of the mouse: a review for geneticists. Adv Genet 1979;20:357-459.
25. Andermann F, Andermann E. Startle disorders of man: hyperekplexia, jumping and startle epilepsy. Brain Dev 1988;10:213-222.